Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00003535
First received: November 1, 1999
Last updated: July 14, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)